Pegylated L-Asparaginase

DRUG2 trials

Sponsors

National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology

Conditions

B Acute Lymphoblastic LeukemiaFallopian Tube NeoplasmsOvarian NeoplasmsPrimary Peritoneal Neoplasms

Phase 2

Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

CompletedNCT01313078

National Cancer Institute (NCI)Fallopian Tube Neoplasms, Ovarian Neoplasms, Primary Peritoneal Neoplasms

Start: 2010-01-31End: 2011-09-30Updated: 2015-10-09

Phase 3

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

RecruitingNCT03150693

Alliance for Clinical Trials in OncologyB Acute Lymphoblastic Leukemia

Start: 2017-09-20End: 2027-08-01Target: 303Updated: 2026-09-02

Related Papers

Increased yield of recurrent structural variants (SVs) in Ph-like B-cell acute lymphoblastic leukemia (B-ALL) using a streamlined clinical whole-genome sequencing (WGS) assay

Blood2025-11-03

Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial

Blood2024-11-0516 citations